Long-term Impact of NMDAR Encephalitis, Level 3 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Long-term Impact of NMDAR Encephalitis, Level 3 — Stella

Home/NMDAR Autoimmune Encephalitis/

View on ClinicalTrials.gov

Recruiting

Back to NMDAR Autoimmune Encephalitis trials

Trial locations(1 site)

France

Centre de référence des syndromes neurologies paranéoplasiques et encéphalites auto-immunes - Hôpital neurologiques Pierre WERTHEIMER - Groupement hospitalier Est - Hospices civiles de Lyon, Bron

Key details

Sponsor

Hospices Civils de Lyon

Collaborators

Charite University, Berlin, Germany

Enrollment target

~30 participants

Started

November 2025

Primary completion

November 2026

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.